S4 + LGD 4033 Tablets

S4 + LGD 4033 Tabs

S4 + LGD 4033 tablets is offered in 2 variants: 40mg per tablet for 27 tablets, totaling 1080mg and 40mg per tablet for 54 tablets, totaling 2160mg.

Andarine S4

A scientific study published in 2005 examined the effects of Andarine S-4 in the skeletal muscles, bones and pituitary glands of castrated male rats. A treatment protocol (3 and 10mg/kg S4- Andarine for 8 weeks) was commenced 12 weeks after castration. Andarine (doses 3 and 10 mg/kg) restored and soleus muscle mass and strength and levator ani muscle mass to that seen prior to castration or in intact animals.

This makes S4 an investigational Selective androgen receptor modulator, for possible treatment of conditions related to muscle wasting, osteoporosis and benign prostatic hyperplasia (BPH). It has the ability to mimics many of the beneficial pharmacologic effects associated with testosterone. Each tablet contains 30mg S4.

LGD 4033

Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis.

Recent studies investigated the effects of LGD 4033 on muscle tissue in ovariectomized rats. A daily dose of LGD was administered and calculated according to body weight of each individual rat at the onset of the study. Results and changes were noted as soon as week 2, the control group having weighed significantly less than rats undergoing LGD treatment. This difference remained until the end of the study, irrespective of LGD treatments. Additionally, the LGD treatments resulted in a higher number of capillaries in all muscles studied. Longer randomized trials and research could potentially evaluate its efficacy in improving physical function and health outcomes in select populations. Each tablet contains 10mg LGD 4033